Benvenga Salvatore, Santarpia Libero, Trimarchi Francesco, Guarneri Fabrizio
Sezione di Endocrinologia del Dipartimento Clinico Sperimentale di Medicina e Farmacologia, Università di Messina, Messina, Italy.
Thyroid. 2006 Mar;16(3):225-36. doi: 10.1089/thy.2006.16.225.
We previously reported that the spirochete Borrelia burgdorferi could trigger autoimmune thyroid diseases (AITD). Subsequently, we showed local amino acid sequence homology between all human thyroid autoantigens (human thyrotropin receptor [hTSH-R], human thyroglobulin [hTg], human thyroperoxidase [hTPO], human sodium iodide symporter [hNIS]) and Borrelia proteins (n = 6,606), and between hTSH-R and Yersinia enterocolitica (n = 1,153). We have now updated our search of homology with Borrelia (n = 11,198 proteins) and extended our search on Yersinia to the entire species (n = 40,964 proteins). We also searched the homologous human and microbial sequences for peptide-binding motifs of HLA-DR molecules, because a number of these class II major histocompatibility complex (MHC) molecules (DR3, DR4, DR5, DR8, and DR9) are associated with AITD. Significant homologies were found for only 16 Borrelia proteins (5 with hTSH-R, 2 with hTg, 3 with hTPO, and 6 with hNIS) and only 19 Yersinia proteins (4 with hTSH-R, 2 with hTg, 2 with hTPO, and 11 with hNIS). Noteworthy, segments of thyroid autoantigens homologous to these microbial proteins are known to be autoantigenic. Also, the hTSH-R homologous region of one Borrelia protein (OspA) contains an immunodominant epitope that others have found to be homologous to hLFA-1. This is of interest, as the hLFA-1/ICAM-1 ligand/receptor pair is aberrantly expressed in the follicular cells of thyroids affected by Hashimoto's thyroiditis. A computer-assisted search detected antigenic peptide binding motifs to the DR molecules implicated in AITD. In conclusion, our in silico data do not directly demonstrate that Borrelia and Yersinia proteins trigger AITD but suggest that a restricted number of them might have the potential to, at least in persons with certain HLA-DR alleles.
我们之前报道过,疏螺旋体伯氏疏螺旋体可引发自身免疫性甲状腺疾病(AITD)。随后,我们发现所有人类甲状腺自身抗原(人类促甲状腺激素受体[hTSH-R]、人类甲状腺球蛋白[hTg]、人类甲状腺过氧化物酶[hTPO]、人类钠碘转运体[hNIS])与伯氏疏螺旋体蛋白(n = 6,606)之间以及hTSH-R与小肠结肠炎耶尔森菌(n = 1,153)之间存在局部氨基酸序列同源性。我们现在更新了与伯氏疏螺旋体(n = 11,198种蛋白质)的同源性搜索,并将对耶尔森菌的搜索扩展至整个物种(n = 40,964种蛋白质)。我们还在同源的人类和微生物序列中搜索了HLA-DR分子的肽结合基序,因为许多此类II类主要组织相容性复合体(MHC)分子(DR3、DR4、DR5、DR8和DR9)与AITD相关。仅发现16种伯氏疏螺旋体蛋白(5种与hTSH-R同源、2种与hTg同源、3种与hTPO同源、6种与hNIS同源)和仅19种耶尔森菌蛋白(4种与hTSH-R同源、2种与hTg同源、2种与hTPO同源、11种与hNIS同源)存在显著同源性。值得注意的是,已知与这些微生物蛋白同源的甲状腺自身抗原片段具有自身抗原性。此外,一种伯氏疏螺旋体蛋白(OspA)的hTSH-R同源区域包含一个免疫显性表位,其他人已发现其与hLFA-1同源。这一点很有意思,因为hLFA-1/ICAM-1配体/受体对在桥本甲状腺炎患者受影响的甲状腺滤泡细胞中异常表达。一项计算机辅助搜索检测到与AITD相关的DR分子的抗原肽结合基序。总之,我们的计算机模拟数据并未直接证明伯氏疏螺旋体和耶尔森菌蛋白会引发AITD,但表明其中数量有限的一些蛋白可能至少在具有某些HLA-DR等位基因的个体中具有引发该病的潜力。